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stenting, OTC application and percutaneous placement of 
drainages resulted in a 100% closure rate. The mortality rate 
and length of stay were not substantially different after both 
treatment regimens.  Conclusion: Endoscopic management 
of anastomotic leakages after LRYGB may constitute a valu-
able alternative therapeutic option to surgical reoperation 
and drainage placement.  © 2014 S. Karger AG, Basel 
 Introduction 
 Bariatric surgery is an effective therapy of morbid 
obesity and its associated comorbidities such as type 2 
diabetes, hypertension, dyslipidemia and obstructive 
sleep apnea  [1–4] . The perioperative complication rate of 
patients undergoing laparoscopic Roux-en-Y gastric by-
pass (LRYGB) is low, and the reported anastomotic leak-
age rate ranges between 1 and 3%  [5] . However, conse-
quences of an anastomotic leakage at the level of the gas-
trojejunostomy can be serious and often result in a 
markedly extended hospital stay and even an increased 
mortality rate  [6] . Management of anastomotic leakages 
can often be difficult and technically demanding. Surgi-
cal revision of anastomotic leakages is usually limited to 
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 Abstract 
 Background: Management of leakages of the gastrojejunal 
anastomosis after laparoscopic Roux-en-Y gastric bypass 
(LRYGB) can be complex. New endoscopic techniques such 
as covered stents and over-the-scope clips (OTCs) have been 
developed and are valuable alternative therapeutic options 
to reoperation and drainage. The aim of this study was to 
compare the value of stents and OTCs with surgical treat-
ment options for the therapy of anastomotic leakages after 
LRYGB.  Methods: Results of patients who were treated surgi-
cally with reoperation, local irrigation and drain placement 
(n = 9) were compared with results of patients who were 
treated endoscopically with stent and/or OTC placement 
(n = 5). Success rate, length of hospital stay, mortality, num-
ber of OTC applications/stent placement and percutaneous 
drainage placements were analyzed.  Results: Overall, 14 of 
1,046 patients (1.34%) developed a leakage of their gastro-
jejunal anastomosis after LRYGB between 2000 and 2012. 
While the success rate in surgically treated patients was 88%, 
the endoscopic treatment using a sequential approach with 
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local irrigation and drain placement due to the present 
inflammatory tissue, which does not allow a repair of the 
fistula. Alternatively, a renewal of the gastrojejunostomy 
may be performed  [7] . However, with the development 
of modern endoscopic devices such as covered stents and 
over-the-scope clips (OTCs), new therapeutic options 
have become available, but experience with these devices 
is still limited  [8–11] . Therefore, we retrospectively ana-
lyzed the outcome of patients who developed a leak at the 
gastrojejunal anastomosis after LRYGB and compared 
the results of surgical and endoscopic treatment strate-
gies.
 Material and Methods 
 Patients and Definitions 
 Data of 1,046 consecutive patients undergoing an LRYGB from 
June 2000 to April 2012 were retrospectively analyzed using a pro-
spectively collected database. Patients with anastomotic leakages 
who received their LRYGB between June 2000 and April 2010 rou-
tinely underwent laparoscopic reoperation with either closure of 
the defect by suture, local irrigation and drainage (n = 7) or re-
newal of the anastomosis (n = 2). After that, our routine manage-
ment of leakages at the level of the gastrojejunostomy after LRYGB 
changed, and we introduced the endoscopic treatment of leakages 
using sequential or combined application of stents and OTCs. If 
necessary, additional percutaneous drain placement was per-
formed by interventional radiology (n = 2). Anastomotic leakages 
at the gastrojejunostomy were diagnosed by upper GI series, com-
puted tomography or upper endoscopy. Outcomes after surgical 
and endoscopic management were assessed and compared for 
time between primary LRYGB and diagnosis, patient’s character-
istics, success rate, time to closure, length of hospital stay and mor-
tality. Time lag from initial procedure (LRYGB) to operative revi-
sion defined the closure time in the surgically treated group. 
Healed leakage was diagnosed endoscopically or by clinical judg-
ment.
 Data are presented as mean ± SD, median plus range. Due to 
the small sample size and distribution, we did not calculate any p 
values.
 Surgery 
 All LRYGB procedures were performed as described by Witt-
grove in 1994. Briefly, a small gastric pouch of approximately 15–
25 ml was created and the jejunum divided 50 ml distal to the 
duodenojejunal flexure. The jejunojejunostomy was performed 
using a linear stapler. The mesenteric window at the jejunojejunos-
tomy was closed with a non-absorbable suture (Ethibond TM ). Ei-
ther an alimentary limb length of 150 cm in the proximal bypass 
or a common channel of 150 cm in the distal bypass was chosen, 
depending on the preoperative body mass index. The gastrojejunal 
anastomosis was performed using a circular stapler (CEEA 25 mm, 
Tyco, Mansfield, Mass., USA). Reoperations were performed lapa-
roscopically including suturing of the leakage if detected early, 
drainage and irrigation (n = 7) or renewal of the gastrojejunostomy 
(n = 2).
 Endoscopy 
 Endoscopies were performed under deep conscious sedation 
with propofol using Olympus endoscopic instruments (Olympus 
Medical Systems, Tokyo, Japan). Endoscopy was performed to-
gether with the bariatric surgeon in the endoscopy unit or bedside 
in the ICU.
 The OTC device has been comprehensively described by its 
inventors  [12] . The system consists of a clip mounted on the distal 
tip of the endoscope, which can be released by a thread connected 
through the working channel to the handwheel of the scope. The 
nitinol clips are highly elastic and have shape memory. Three dif-
ferent sizes of clips are currently available that when closed will 
cover lesions up to 2–3 cm in diameter depending on the elastic-
ity of tissue. ERCP cannula catheters together with 0.035-inch 
guide wires are used to detect and visualize fistula orifices and 
tracts under fluoroscopy. OTCs were placed with the help of dif-
ferent endoscopic equipment. Simple suction, an anchoring de-
vice or specially designed forceps called twin grasper were used to 
grab tissue around the fistula and pull it into the delivery cap of 
the OTCs. The choice of instrument was at the discretion of the 
endoscopist.
 All stents were placed over a super-stiff Amplatz (Boston Sci-
entific Corp., Natick, Mass., USA) guide wire either under direct 
visual control by side-by-side endoscopy or assisted by fluoros-
copy. We used the following stent types: Ultraflex partially covered 
SEMS with a diameter of 23/28 mm and length from 9 to 12 cm 
(Boston Scientific Corp., Natick, Mass., USA) or Niti-S fully cov-
ered MEGA or BETA stent (Taewoong Medical, Korea), which are 
specially designed for leakages after bariatric surgery. Stents were 
left in place for 2–3 weeks, and then extracted endoscopically using 
rat tooth forceps. In the same session, reevaluation of the leak was 
performed and in case of persistence again treated in the above-
mentioned manner if technically possible.
 Results 
 In total, 1,046 patients underwent LRYGB between 
June 2000 and April 2012 in our institution, 14 of which 
developed a leakage at the level of the gastrojejunostomy. 
Of these, 9 patients were treated surgically and 5 received 
endoscopic treatment. Patient characteristics of the two 
groups are shown in  table 1 . Surgical treatment consisted 
of laparoscopic reoperation, defect closure, local irriga-
tion and drain placement (n = 7) or renewal of the gastro-
jejunostomy (n = 2) and led to successful leak closure in 
a total of 8 patients (88%). In one patient, however, surgi-
cal treatment remained unsuccessful despite a relaparot-
omy, and the patient died 44 days after the primary op-
eration due to persistent leakage and septicemia.
 Endoscopic treatment was performed sequentially 
and consisted of endoscopic stenting, OTC application 
and percutaneous placement of drainages if necessary. In 
total, 6 stents, 10 OTCs and 2 percutaneous drainages 
were applied sequentially in 5 patients leading to a 100% 
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success rate. However, as shown in  table 2 , endoscopic 
treatment was associated with a substantially longer time 
to leak closure when compared with surgery (5 vs. 28 
days). Furthermore, length of hospital stay was also 
slightly longer after endoscopic treatment (34 vs. 23 
days). The time to diagnosis was comparable in both 
groups ( table 2 ). The approximated mean cost for a pa-
tient without a leakage was USD 26,400. In the case of a 
leakage at the gastrojejunostomy, the cost increased dra-
matically to USD 80,900. The average cost of the endo-
scopic treatment per patient including stents and OTC 
was USD 10,560.
 Discussion 
 The reported incidence of gastrojejunal leakages after 
LRYGB has been reported to range between 1 and 3%  [5] . 
The management of leakages in obese patients after 
LRYGB can be complex and technically demanding and 
results in significant morbidity with prolonged hospital 
stay in most cases  [7] . Early detection and successful 
management of leakages are therefore crucial in order to 
achieve a beneficial outcome. Our results suggest that an 
endoscopic therapy approach consisting of stent and 
OTC placement may be a valuable alternative to surgical 
intervention in patients with small leakages and adequate 
drainage. Further, the endoscopic technique seems to be 
at least equally safe with a similar success rate when com-
pared to the traditional operative management.
 We further observed that the time to closure and 
length of hospital stay were slightly longer in endoscopi-
cally treated patients, highlighting possible limitations of 
the interventional strategy. However, the definition of the 
time to closure is difficult, and the interpretation of these 
results should be taken carefully. Our results are compa-
rable to a recently published study summarizing the re-
sults of 7 studies including 67 patients whose leakages af-
ter LRYGB were treated with self-expandable stents lead-
ing to a success rate of 88%  [13] . It was further shown that 
stent migration was a frequent problem in up to 36% of 
the cases, especially when fully covered self-expanding 
stents were used under ‘benign’ circumstances like leaks 
and fistulas  [14] , which can be observed in up to 42% of 
cases. In our series, 2 of 6 stents migrated during the 
course of treatment as documented by endoscopy or ra-
diography. Stent migration might be explained by differ-
ences in stent design, which has to be chosen properly. 
Nowadays, more sophisticated stent models are available, 
leading to a greater variety of possible choices. Therefore, 
a case-oriented, tailored approach appears feasible. For 
example, the first generation of covered stents was pre-
dominantly designed for esophageal placement alone. 
Over time, specially designed anti-migration specifica-
tions were added, and uncovered segments were intro-
duced later on to allow tissue overgrowth and therefore 
hinder migration. Only recently have stents specifically 
designed for leaks after bariatric surgery become avail-
able, providing better anchoring and coverage of complex 
leaks at the stapler sites  [15] .
 In our series, we did not observe life-threatening com-
plications of the interventional approach such as forma-
tion of abscesses or bleeding. If migrated, stents could be 
retrieved endoscopically without serious consequences 
and replaced in the same session.
 We are fully aware of the fact that the low number of 
included patients and the heterogeneous characteristics 
do not allow any firm conclusion based on the presented 
results. Thus, the optimal indication and timing of stent 
and OTC placement still remain unclear and need further 
investigation.
 In conclusion, sequential stent and OTC placement 
seems to be a valuable therapeutic option for the treat-
 Table 1.  Patient characteristics
Surgical group Endoscopic group
Mean age, years 43.4 ± 10.6 52 ± 11.3
Mean BMI (kg/m2) 45.8 ± 7.3 37.4 ± 6.5
Number of leakages 9 5
Male/female 6/3 1/4
 Values are given as mean ± SD. BMI = Body mass index.
 Table 2.  Outcomes in patients with leakage of the gastrojejunos-
tomy after surgical treatment (n = 9) and endoscopic treatment
(n = 5)
Surgical group Endoscopic group
Time to diagnosis, days 4 (1 – 9) 3 (1 – 5)
Success rate 8/9 (88%) 5/5 (100%)
Time to closure, days 5 (1 – 44) 28 (25 – 58)
Length of hospital stay, days 23 (9 – 53) 34 (32 – 41)
Mortality 11% 0%
 Time values are expressed as median (range).
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ment of acute gastrojejunal leakages after LRYGB in pa-
tients with small anastomotic leakages and adequate 
drainage. The results are comparable to the conventional 
surgical management. Further experience and studies are 
needed to gain more evidence.
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